Category: Congress Info

In a promising breakthrough against antibiotic-resistant infections, researchers have harnessed personalized bacteriophage therapy to combat Pseudomonas aeruginosa in adults with cystic fibrosis (CF). The innovative approach—designed to exploit bacterial “trade-offs” that weaken resistance or virulence—was used to treat nine CF patients with compassionate-use nebulized phage therapy. The results were encouraging: bacterial load in patients’ lungs…

    A Practical Guide Covering Technical, Regulatory, and Business Aspects   Targeting Phage Therapy 2025 is dedicating a practical session to “How to Produce, Manufacture, and Bring Phage Products to Market”.  This session provides a comprehensive and hands-on approach to the entire phage product lifecycle, from laboratory preparation to industrial-scale production and market entry.…

The 7th World Congress on Targeting Phage Therapy 2024 took place on June 20-21 in Malta, attracting over 100 participants from more than 30 countries. The event included over 40 presentations, comprising major talks, short orals, and posters. Dr. Jean Paul Pirnay concluded the conference with remarks emphasizing the critical role of personalized phage therapy…